-
Vaccines, Blood & Biologics
-
Resources for You
-
-
FluLaval
Proper Name: Influenza Virus Vaccine
Tradename: FluLaval
Manufacturer: ID Biomedical Corporation of Quebec, License #1739
Indications:
- Active immunization of adults 18 years of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
-
Supporting Documents
- July 10, 2009 Approval Letter - FluLaval
New Formulation: 2009/2010 Season Formulation - July 28, 2008 Approval Letter - FluLaval
New Formulation: 2008-2009 United States formulation. - May 16, 2008 Approval Letter - FluLaval
Package Insert Changes: Update the language in the package insert to be consistent with new content and format labeling requirements. - September 12, 2007 Approval Letter - FluLaval
New Formulation: 2007-2008 United States formulation. - October 5, 2006 Approval Letter - FluLaval
Indication: Active immunization of adults 18 years of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. - FDA Approves Additional Vaccine for Upcoming Influenza Season
Press Release: October 5, 2006
-
-
-